Benfotiamine 120 C by Xymogen
Benfotiamine 120 C is a multi-purpose product designed by Xymogen.* You can take it as a cardiovascular supplement, as well as to promote your nerve health and thiamin status.* It contains Benfotiamine, a lipid-soluble derivative of thiamin that can be absorbed more effectively by your body and can support your conversion of harmful glucose metabolites, hence its potential health benefits.*
Who Should Consider Benfotiamine 120 C?
Benfotiamine 120 C may support your health if you:
- struggle with nerve discomfort, tingling or numbness in your hands and feet*
- want to reduce the impact of high glucose levels*
- wish to support your overall health and wellness*
Benfotiamine 120 C by Xymogen—Effects
Xymogen Benfotiamine 120 C may:
- support healthy thiamin status*
- aid vascular health*
- promote nerve health*
Supplements support your health but do not replace a balanced diet. Always check with your healthcare practitioner if you have doubts about a new supplement. Book a FREE product consultation to learn more about Benfotiamine 120 C by Xymogen.
Recommendation:
Xymogen suggests taking two capsules in the morning and two capsules in the evening, or as directed by your healthcare professional.
Serving Size: 2 Capsules
Servings Per Container: 60
Amount Per Serving:
Benfotiamine 300 mg
Other Ingredients: Microcrystalline cellulose, capsule (hypromellose and water), ascorbyl palmitate, silica, and medium-chain triglyceride oil.
Does Not Contain: Wheat, gluten, corn protein, yeast, soy, animal or dairy products, artificial colors, artificial sweeteners, or preservatives.
Caution: Consult your healthcare professional prior to use. Individuals taking medication should discuss potential interactions with their healthcare professional. Do not use if tamper seal is damaged.
Storage: Keep tightly closed in a cool, dry place.
LEGAL NOTICE: Xymogen's Exclusive Professional Formulas are available through select licensed health care professionals. The Internet Sale and Discounting of XYMOGEN formulas are strictly prohibited.
*These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.
Click here to view Product Info Sheet
References:
- Winkler, G., Pál, B., Nagybégányi, E., Ory, I., Porochnavec, M., & Kempler, P. (1999). Effectiveness of different benfotiamine dosage regimens in the treatment of painful diabetic neuropathy. Arzneimittelforschung, 49(3), 220–224. https://doi.org/10.1055/s-0031-1300405
- Loew, D. (1996). Pharmacokinetics of thiamine derivatives especially of benfotiamine. International Journal of Clinical Pharmacology and Therapeutics, 34(2), 47–50. https://pubmed.ncbi.nlm.nih.gov/8929745/
- Brownlee, M. (2005). The pathobiology of diabetic complications: A unifying mechanism. Diabetes, 54(6), 1615–1625. https://doi.org/10.2337/diabetes.54.6.1615
- Giacco, F., & Brownlee, M. (2010). Oxidative stress and diabetic complications. Circulation Research, 107(9), 1058–1070. https://doi.org/10.1161/CIRCRESAHA.110.223545
- Hammes, H.-P., Du, X., Edelstein, D., Taguchi, T., Matsumura, T., Ju, Q., Lin, J., Bierhaus, A., Nawroth, P. P., Hannak, D., Neumaier, M., Bergfeld, R., Giardino, I., & Brownlee, M. (2003). Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy. Nature Medicine, 9(3), 294–299. https://doi.org/10.1038/nm834
- Balakumar, P., Rohilla, A., Krishan, P., & Thangathirupathi, A. (2010). The multifaceted therapeutic potential of benfotiamine. Pharmacological Research, 61(6), 482–488. https://doi.org/10.1016/j.phrs.2010.02.004
- Thornalley, P. J. (2005). The potential role of thiamine (vitamin B1) in diabetic complications. Current Diabetes Reviews, 1(3), 287–298. https://doi.org/10.2174/157339905774574593